Paperpal Prime Logo

MedChemComm : Impact Factor & More

eISSN: 2040-2511pISSN: 2040-2503

Key Metrics

CiteScore
2.24
H-Index
44
SNIP
0.72
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on MedChemComm

MedChemComm Journal Specifications

Indexed in the following public directories

  • CrossRef CrossRef
  • SJR SJR
  • Scopus Scopus
Overview
Publisher Royal Society of Chemistry

Planning to publish in MedChemComm ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in MedChemComm

Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays
  • 29 Jul 2026
  • RSC Medicinal Chemistry
Synthesis and anti-inflammatory activity evaluation of pterostilbene-based phthalide derivatives.
  • 28 Jul 2026
  • RSC medicinal chemistry
Integrated platform for accelerating therapeutic macrocyclic peptide purification in high-throughput medicinal chemistry.
  • 27 Jul 2026
  • RSC medicinal chemistry
Peptide-drug conjugation: a strategy to address blood-brain barrier limitations in central nervous system diseases.
  • 27 Jul 2026
  • RSC medicinal chemistry
Targeting PRMTs with small-molecule inhibitors: a comprehensive review.
  • 27 Jul 2026
  • RSC medicinal chemistry
Discovery of spirocyclic amide scaffolds as novel neddylation E1 inhibitors to suppress the growth and survival of lung cancer cells.
  • 17 Jul 2026
  • RSC medicinal chemistry
Probing pyrazolo-pyrimidines as SIRT2 inhibitors via molecular modelling and biological assays
  • 29 Jul 2026
  • RSC Medicinal Chemistry
Synthesis and anti-inflammatory activity evaluation of pterostilbene-based phthalide derivatives.
  • 28 Jul 2026
  • RSC medicinal chemistry
Integrated platform for accelerating therapeutic macrocyclic peptide purification in high-throughput medicinal chemistry.
  • 27 Jul 2026
  • RSC medicinal chemistry
Peptide-drug conjugation: a strategy to address blood-brain barrier limitations in central nervous system diseases.
  • 27 Jul 2026
  • RSC medicinal chemistry
Targeting PRMTs with small-molecule inhibitors: a comprehensive review.
  • 27 Jul 2026
  • RSC medicinal chemistry
Discovery of spirocyclic amide scaffolds as novel neddylation E1 inhibitors to suppress the growth and survival of lung cancer cells.
  • 17 Jul 2026
  • RSC medicinal chemistry

FAQs on MedChemComm